diacerein has been researched along with Inflammation in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 9 (50.00) | 24.3611 |
2020's | 5 (27.78) | 2.80 |
Authors | Studies |
---|---|
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
Fotio, Y; Lodola, A; Mor, M; Piomelli, D; Scalvini, L; Spadoni, G; Tarzia, G | 1 |
He, A; Huang, L; Li, Y; Luo, M; Lv, D; Shen, J; Xue, Y | 1 |
Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Yu, T; Zou, C | 1 |
Abdel-Nasser, ZM; Abdeldaiem, MSI; Abdelhady, R; Alhajlah, S; AlOmeir, O; Alrouji, M; El Adle Khalaf, N; El-Bahouty, WB; El-Gharbawy, DM; Elrabat, A; Ewees, MGE; Ghaffar, DMA; Haleem, AA; Kaddah, MMY; Mohammed, OA; Saber, S; Shata, A; Zakaria, S; Zohny, MH | 1 |
Chang, CY; Chen, CS; Chen, JJ; Gan, D; Ku, H; Lin, CH; Lin, HJ; Tien, PT; Tsai, YY; Wan, L | 1 |
Bao, L; Chan, LS; Many, B; Mohan, GC; Zhang, H | 1 |
Arjinajarn, P; Chatsudthipong, V; Chattipakorn, N; Chueakula, N; Jaikumkao, K; Lungkaphin, A; Pongchaidecha, A | 1 |
Camey, S; Fuchs, SC; Koehler-Santos, P; Lisboa, HK; Moreira, LB; Pereira, FDS; Piovesan, F; Tres, GS | 1 |
Dong, X; Jin, Y; Li, B; Liu, C; Liu, Q; Tang, K; Wang, Y; Yu, G; Zhang, W | 1 |
Abd-Ellatif, RN; Atef, MM; Hafez, YM; Hegab, II; Sadek, MT | 1 |
Kullich, W; Lohberger, B; Steinecker-Frohnwieser, B; Weigl, L | 1 |
Jatwa, R; Kar, A | 1 |
Joo, NS; Kim, BT; Kim, CW; Kim, KM; Kim, SM; Lee, DJ | 1 |
Calisto, KL; Camacho, AC; Carvalheira, JB; Carvalho, BM; Guadagnini, D; Mittestainer, FC; Saad, MJ | 1 |
Kosaka, N; Ohmori, K; Shirai, T; Takafumi, N; Tamura, T | 1 |
Calixto, JB; Campos, MM; Medeiros, R; Quintão, NLM; Santos, ARS | 1 |
Cairo, G; Garuti, C; Montosi, G; Pietrangelo, A; Recalcati, S | 1 |
1 review(s) available for diacerein and Inflammation
2 trial(s) available for diacerein and Inflammation
Article | Year |
---|---|
Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial.
Topics: Aged; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Male; Middle Aged; Treatment Outcome | 2018 |
Changes of body weight and inflammatory markers after 12-week intervention trial: results of a double-blind, placebo-control pilot study.
Topics: Absorptiometry, Photon; Adiponectin; Adult; Anthraquinones; Anti-Inflammatory Agents; Appetite Depressants; C-Reactive Protein; Cyclobutanes; Double-Blind Method; Female; Humans; Inflammation; Lipoproteins, LDL; Male; Obesity; Pilot Projects; Tumor Necrosis Factor-alpha; Waist Circumference; Weight Loss | 2011 |
15 other study(ies) available for diacerein and Inflammation
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Diacerein attenuates vascular dysfunction by reducing inflammatory response and insulin resistance in type 2 diabetic rats.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Aorta, Thoracic; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Insulin Resistance; Male; Molecular Structure; NF-kappa B; Nitric Oxide Synthase; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.
Topics: Angiotensin II; Animals; Anthraquinones; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA; Ventricular Remodeling | 2022 |
Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis.
Topics: Animals; Anthraquinones; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Rats; Sulfates | 2022 |
Diacerein Inhibits Myopia Progression through Lowering Inflammation in Retinal Pigment Epithelial Cell.
Topics: Animals; Anthraquinones; Cricetinae; Epithelial Cells; Inflammation; Myopia; Retinal Pigments | 2021 |
Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.
Topics: Anthraquinones; Anti-Inflammatory Agents; Atherosclerosis; Cells, Cultured; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Interleukin-1alpha; Interleukin-1beta; Keratinocytes; Oligonucleotide Array Sequence Analysis; Osteoarthritis; Psoriasis; Real-Time Polymerase Chain Reaction | 2017 |
Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Antioxidants; Creatinine; Diet, High-Fat; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Kidney; Obesity; Organic Anion Transporters, Sodium-Independent; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2018 |
Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice.
Topics: Acute Kidney Injury; Animals; Anthraquinones; Anti-Inflammatory Agents; Cytokines; Endotoxemia; Inflammation; Kidney; Male; Mice, Inbred C57BL | 2018 |
Diacerein protects against glycerol-induced acute kidney injury: Modulating oxidative stress, inflammation, apoptosis and necroptosis.
Topics: Acute Kidney Injury; Animals; Anthraquinones; Apoptosis; DNA Damage; Glycerol; Inflammation; Male; Necrosis; Oxidative Stress; Rats; Rats, Wistar | 2019 |
The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli.
Topics: Anthraquinones; Antirheumatic Agents; Cell Line; Cell Proliferation; Cell Survival; Cells, Cultured; Chondrocytes; Collagen Type I; Fibronectins; Glycosaminoglycans; Humans; Inflammation; Interleukin-1beta; Interleukin-8; Matrix Metalloproteinase 1; Osteoarthritis; Physical Stimulation; Stress, Mechanical | 2014 |
Anti-inflammatory and anti-peroxidative roles of diacerein are possibly mediated through an alteration in thyroid functions in animal model of inflammation.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Carrageenan; Cholesterol; Disease Models, Animal; Female; Glutathione; Inflammation; Insulin; Lipid Peroxidation; Rats; Rats, Wistar; Thyroid Hormones; Triglycerides | 2009 |
Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis.
Topics: Adipose Tissue; Animals; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Cytokines; Inflammation; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Rats, Wistar; Sepsis; Signal Transduction | 2012 |
Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Resorption; Edema; Female; Inflammation; Male; Mice; Osteocalcin; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rats, Wistar | 2002 |
The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice.
Topics: Amines; Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Cyclohexanecarboxylic Acids; Disease Models, Animal; Female; Gabapentin; gamma-Aminobutyric Acid; Inflammation; Mice; Pain; Sciatic Neuropathy | 2005 |
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes.
Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Humans; Inflammation; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Monocytes; Nitric Oxide; RNA-Binding Proteins | 1998 |